Gastro-intestinal (GI) cancer is the most common form of cancer. More than 24,000 Australians are diagnosed with GI cancer each year and 33 Australians die from the disease each day.
Major advances in treating GI cancers and improving patient quality of life are possible because of research and clinical trials.
We improve the health and quality of life of patients with Gastro-Intestinal cancer by developing and conducting impartial and collaborative multi-disciplinary trials.
The Australasian Gastro-Intestinal Trials Group (AGITG) and the GI Cancer Institute addresses key unanswered research questions about GI cancer to discover and develop breakthrough treatments for GI cancer.